John Carreyrou - Bad blood

Paperback editie in goede staat. Engelstalig.

Samenvatting: in 2014, Theranos founder and ceo Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as larry ellison and tim draper, theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes' worth at an estimated $4.5 Billion. There was just one problem: the technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments.